208 related articles for article (PubMed ID: 12974441)
1. Antituberculous therapy-induced toxicity.
Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
[TBL] [Abstract][Full Text] [Related]
2. [Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
Wikman PE; Jover F; Peris J; Cuadrado JM
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):132-3. PubMed ID: 19254644
[No Abstract] [Full Text] [Related]
3. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Stout JE
Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid induced gynaecomastia: a case report.
Garg R; Vaibhav ; Mehra S; Prasad R
Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
[TBL] [Abstract][Full Text] [Related]
5. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
Dixit R; Sharma S; Nawal CL
J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
[No Abstract] [Full Text] [Related]
6. Genitourinary tuberculosis. A study of 1117 cases over a period of 34 years.
Gow JG; Barbosa S
Br J Urol; 1984 Oct; 56(5):449-55. PubMed ID: 6534442
[TBL] [Abstract][Full Text] [Related]
7. [Case of fatal liver failure due to anti-tuberculous therapy].
Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
[TBL] [Abstract][Full Text] [Related]
8. [Principles of drug therapy in urogenital tuberculosis].
Jungbluth H
Urologe A; 1984 Jul; 23(4):189-93. PubMed ID: 6540914
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid associated, painful, bilateral gynaecomastia.
Khanna P; Panjabi C; Maurya V; Shah A
Indian J Chest Dis Allied Sci; 2003; 45(4):277-9. PubMed ID: 12962465
[TBL] [Abstract][Full Text] [Related]
10. [Fulminant hepatitis during the therapy for tuberculous meningitis].
Garavelli PL
Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
[No Abstract] [Full Text] [Related]
11. [Hypothermia due to anti-tuberculosis drugs: first case].
Oualil H; Nejjari S; Bourkadi JE; Iraqi G
Rev Pneumol Clin; 2014 Oct; 70(5):298-301. PubMed ID: 24646781
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic insufficiency due to antituberculous therapy.
Liu BA; Knowles SR; Cohen LB; Werb MR; Shear NH
Ann Pharmacother; 1997 Jun; 31(6):724-6. PubMed ID: 9184712
[TBL] [Abstract][Full Text] [Related]
13. Pyrazinamide-induced granulomatous hepatitis.
Knobel B; Buyanowsky G; Dan M; Zaidel L
J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
15. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
Durand F; Bernuau J; Pessayre D; Samuel D; Belaiche J; Degott C; Bismuth H; Belghiti J; Erlinger S; Rueff B
Hepatology; 1995 Apr; 21(4):929-32. PubMed ID: 7705802
[TBL] [Abstract][Full Text] [Related]
16. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
[TBL] [Abstract][Full Text] [Related]
17. Acute liver failure caused by isoniazid in a child receiving carbamazepine.
Berkowitz FE; Henderson SL; Fajman N; Schoen B; Naughton M
Int J Tuberc Lung Dis; 1998 Jul; 2(7):603-6. PubMed ID: 9661830
[TBL] [Abstract][Full Text] [Related]
18. Recurrent dysosmia induced by pyrazinamide.
El Aïdli S; Kastalli S; Zaïem A; Lakhoua G; Rejeibi I; Loueslati MH; Daghfous R; Belkahia C
Fundam Clin Pharmacol; 2009 Oct; 23(5):539-41. PubMed ID: 19674115
[TBL] [Abstract][Full Text] [Related]
19. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions observed during DOTS.
Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
